• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by LivaNova PLC

< Previous 1 2 3 Next >
News headline image
LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
February 25, 2026
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
January 20, 2026
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Present at J.P. Morgan Healthcare Conference in January
December 23, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
December 03, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
December 02, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Present at Piper Sandler Healthcare Conference in December
November 25, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
November 24, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
November 12, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
November 05, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Present at Wolfe Research Healthcare Conference in November
October 23, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Announce Third-Quarter 2025 Results
October 08, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
October 07, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Appoints Donald Zurbay as a New Director
September 04, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Host Investor Day on November 12, 2025
August 25, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
August 22, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Launches Essenz Perfusion System in China
August 18, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance
August 06, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Announce Second-Quarter 2025 Results
July 09, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
June 05, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
June 05, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
June 04, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Present at the Jefferies Global Healthcare Conference
May 15, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
May 07, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
May 07, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Announce First-Quarter 2025 Results
March 26, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance
February 25, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Present at the Barclays Global Healthcare Conference
February 21, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
January 21, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
January 06, 2025
From LivaNova PLC
Via Business Wire
Tickers LIVN
News headline image
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
December 18, 2024
From LivaNova PLC
Via Business Wire
Tickers LIVN
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap